Open AccessCefoxitin as an Alternative to Carbapenems in a Murine Model of Urinary Tract Infection Due to Escherichia coli Harboring CTX-M-15-Type Extended-Spectrum β-Lactamase
Author(s) -
R. Lepeule,
Étienne Ruppé,
Patrick Lê,
Laurent Massias,
Françoise Chau,
Amandine Nucci,
A. Lefort,
Bruno Fantin
Publication year - 2012
Publication title -
antimicrobial agents and chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.07
H-Index - 259
eISSN - 1070-6283
pISSN - 0066-4804
DOI - 10.1128/aac.06233-11
Subject(s) - cefoxitin , ertapenem , imipenem , microbiology and biotechnology , escherichia coli , ceftriaxone , antibiotics , carbapenem , imipenem/cilastatin , biology , chemistry , bacteria , antibiotic resistance , staphylococcus aureus , biochemistry , gene , genetics
We investigated the efficiency of the cephamycin cefoxitin as an alternative to carbapenems for the treatment of urinary tract infections (UTIs) due toEscherichia coli producing CTX-M-type extended-spectrum β-lactamases. The susceptible, UTI-inducingE. coli CFT073-RR strain and its transconjugant CFT073-RR Tc (pbla CTX-M-15 ), harboring abla CTX-M-15 carrying-plasmid, were used for all experiments. MICs of cefoxitin (FOX), ceftriaxone (CRO), imipenem (IMP), and ertapenem (ETP) for CFT073-RR and CFT073-RR Tc (pbla CTX-M-15 ) were 4 and 4, 0.125 and 512, 0.5 and 0.5, and 0.016 and 0.032 μg/ml, respectively. Bactericidal activity was similarly achievedin vitro against the two strains after 3 h of exposure to concentrations of FOX, IMI, and ETP that were 2 times the MIC, whereas CRO was not bactericidal against CFT073-RR Tc (pbla CTX-M-15 ). The frequencies of spontaneous mutants of the 2 strains were not higher for FOX than for IMP or ETP. In the murine model of UTIs, mice infected for 5 days were treated over 24 h. Therapeutic regimens in mice (200 mg/kg of body weight every 3 h or 4 h for FOX, 70 mg/kg every 6 h for CRO, 100 mg/kg every 2 h for IMP, and 100 mg/kg every 4 h for ETP) were chosen in order to reproduce the percentage of time that free-drug concentrations above the MIC are obtained in humans with standard regimens. All antibiotic regimens produced a significant reduction in bacterial counts (greater than 2 log10 CFU) in kidneys and bladders for both strains (P < 0.001) without selecting resistant mutantsin vivo , but the reduction obtained with CRO against CFT073-RR Tc (pbla CTX-M-15 ) in kidneys was significantly lower than that obtained with FOX. In conclusion, FOX appears to be an effective therapeutic alternative to carbapenems for the treatment of UTIs due to CTX-M-producingE. coli .